Changes in catecholamines and acetylcholinesterase levels of crebellum, mid-brain and brain cortex in chromium treated rats

Iranian Journal of Pharmaceutical Research

Volumn 3, Issue 3, 2004, Pages 149-153

  Moshtaghie, Ali Asghar ^a   Afrang, Mohammad ^a   Mesripour, Manuchehr ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acetylcholinesterase; Catecholamine; Chromium; Neurological disease

Indexed keywords

EID: 35348996605     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: 10.22037/ijpr.2010.592     Document Type: Article

References (36)

1. Stocker B J. Chromium absorption, safety and toxicity. J. Trace elements Experimental Medicine (1999) 12: 163-169
2. Anderson R A. Nutritional role of chromium. Sci. Total Environ. (1981) 17: 13-19
3. Fishbein L. Source, transport and alteration of metal compounds and overview. Arsenic, beryllium, cadmium, chromium and nickel. Environ. Health Perspct. (1981) 40: 143-65
4. Flora S D, Serra B D and Zanacchi P. Genotoxicity of chromium compounds. A. Review. Mutat. Res. (1990) 238: 99-172
5. Pankow J F. Analysis for chromium traces in aquatic ecosystem. A study of Cr (II) and Cr (VI) in the Susquehanna River Baisen New York and Pennsylvania. Sci. Total Environ. (1977) 7: 17-25
6. Baron D, Palmer C D and Stamely I. Identification of two iron chromate precipitates in a chromium contamitant soil. Sci. Technol. (1996) 30: 964-968
7. Beaubien S, Nriagu J, Blowes D and Lawson G. Chromium speciation and distribution in the Greate Lakes. Environ. Sci. Technol. (1994) 28: 730-7388
8. Steans D M, Kennedy K D, Courtney P H, Giangrande L S and Phieffer K E. Reduction of chromium (VI) by ascorbate lead to chromium-DNA binding and DNA streand breaks in vitro. Biochemistry (1995) 34: 910-919
9. Standeven A M and Wetterhahn K E. Ascorbate is the principle reductant of chromium (VI) in rat liver and kidney ultrafiltrates. Carcinogens (1991) 12: 1733-1734
10. Ning I and Grant M N. Chromium (VI) induced cytotoxicty to osteoblast-derived cells. Toxicol. (1999) 13: 879-887
11. Malecka J, Greszczak W, Zukowska E A, Jendryczko A and Baczynski R. Concentration of chromium in blood serum of patients with chronic renal failure. Pol. Arch. Med. Wewn. (1995) 93: 25-31
12. Henderson I, Leung A and Halls D. Hyperchromia in chronic dialysis patients. Proc. EDTA. ERA (1985) 22: 270-275
13. Swen A, Derita M V, Michellis M F, Anderson R and Preuss H. Effect of chromium supplement on hemodialysis. Neph. (1996) 7: 1465-1470
14. Leung A T, Henderson L, Kennedy A C, Halls D J and Fell GS. Chromium transfer studies in hemodialysis and continous ambulatory peritoneal dialysis. In: Taylor A. (ed.) Aluminum and other Trace Elements in Renal Ddisease. Bailliere Tindall, London (1986) 332-336
15. Salgado R A and Rodriguez Bitahan J B. Blood levels of chromium in diabetics and non-diabetics hemodialysis patients. Transplantation Proceeding (1996) 28: 3382-3384
16. Haese D, Couttenye P C, Lamberts M, Elseviers L V, Goodman M M, Schrooten W G, Cabera I and De-Broe W E. Aluminium, iron, cadmium, chromium, magnesium, strontium and calcium content in bone of end-stage renal failure. Clin. Chem. (1999) 45: 1548
17. Moshtaghie A A and Ani M. Comparative binding study of aluminum and chromium to human transferrin effect of iron. Biol. Trace Element Res. (1992) 32: 39-46
18. Brock J H. Transferrin. In: Harison PM. (ed.) Metaloproteins. Vol. II. McMillan, London (1985) 183-262
19. Moshtaghie A A, Badii A and Hasanzadeh T. Role of ceruloplasmin and ethamalamine in Manganase binding to serum apotranferrin. Iranian J. Sci. Technol. (1997) 21: 157-168
20. Moshtaghie A A and Badii A. Comparative binding studies of Zinc and Iron to serum human transferrin. Iranian J. Sci. Technol.(1996) 20: 177-188
21. Moshtaghie A A, Taghikhani M and Sandughchin M. Cadmium interaction with iron metabolism. Clin. Chem. Enzyme Comm. (1997) 7: 307-316
22. Moshtaghie A A and Ghaffari M. Identification of amino acids involved in indium binding to serum human apotransferrin. Iranian Biomed. J. (2001) 5: 149-153
23. Ani M and Moshtaghie A A. The effect of chromium on parameters related to iron metabolism. Biol. Trace Element. Res. (1992) 32: 57-64
24. Morris C M, Court J A and Moshtaghie A A. Transferrin and transferrin receptors in normal brain and in Alzheimerís disease. Biochem. Soc. Transaction (1985) 15: 891-892
25. Messripour M and Haddady H. Effect of ascorbic acid administration on copper-induced changes in rat brain hypothalamic catecholamine contents. Acta Neurol. Scand. (1988) 77: 481-5
26. Lowry O H, Rosenbrough N Y, Farr A L and Randall R Y. Protein measurement with folin reagent. J. Biol. Chem. (1951) 193: 265-75
27. Moshtaghie A A, Rahimi S and Messripour M. Aluminum administration on acetylcholinesterase activity of different regions of rat brain. Medical J. of Islamic Academic of Science (1999) 12: 105-108
28. Moshtaghie A A, Saundughchin M, Badii A and Azani M. Development of a method for aluminum determination in serum and dialysis fluid by flameless atomic absorption with graphite furnace. Med. J. I.R.I. (1995) 9: 233-237
29. Rudolf E. A review of findings on chromium toxcicity. Acta Medica Hsadec-kralove. (1997) 41: 55-65
30. Schiffi H, Weidmann P, Weiss M and Massry S G. Dialysis treatment of acute chromium intoxication and comparative efficacy of peritoneal versus hemodialysis in chromium removal. Min. Elec. Met. (1982) 7: 28-35
31. Thompson M M, Sterens B Y, Humphery T Y and Adoins R C. Comparison of trace elements in peritoneal dialysis, hemodialysis and uremia. Kidney Int. (1983) 23: 9-14
32. Wilks M F, Kwizera E N and Bach P H. Assessment of heavy metal nephrotoxicity in vitro using isolated rat glomeruli and proximal tubular fragmerts. Ren. Physiol. Biochem. (1990) 13: 275-84
33. Biandi V, Toso R D, Debetto P, Levis A G, Luciani S, Majone F and Tamino G. Mechanism of chromium toxicity in mammalian cell culture. Toxicol. (1980) 17: 219-224
34. O`Brien T S O, Ceryak S and Patierno S R. Complexities of chromium carcinogenesis. Role of cellular response, repair and recovery mechanisms. Mutat. Res. (2003) 533: 3-36
35. Moshtaghie A A, Rahimi S and Messripour M. Changes in catecholamine levels of cerbellum, mid-brain and brain cortex in aluminium intoxified rats. Indian J. Pharmacol. (1996) 28: 244-248
36. Crapper DR and Tomoko GJ. Neuronal correlates of an encephalopathy associated with aluminum neurofibrillary degeneration. Brain Res. 97: 253-264